| Literature DB >> 32759337 |
Craig Stephens1,2, Tyler Arismendi3, Megan Wright3, Austin Hartman3, Andres Gonzalez3, Matthew Gill3, Mark Pandori4, David Hess3.
Abstract
The evolution and propagation of antibiotic resistance by bacterial pathogens are significant threats to global public health. Contemporary DNA sequencing tools were applied here to gain insight into carriage of antibiotic resistance genes in Escherichia coli, a ubiquitous commensal bacterium in the gut microbiome in humans and many animals, and a common pathogen. Draft genome sequences generated for a collection of 101 E. coli strains isolated from healthy undergraduate students showed that horizontally acquired antibiotic resistance genes accounted for most resistance phenotypes, the primary exception being resistance to quinolones due to chromosomal mutations. A subset of 29 diverse isolates carrying acquired resistance genes and 21 control isolates lacking such genes were further subjected to long-read DNA sequencing to enable complete or nearly complete genome assembly. Acquired resistance genes primarily resided on F plasmids (101/153 [67%]), with smaller numbers on chromosomes (30/153 [20%]), IncI complex plasmids (15/153 [10%]), and small mobilizable plasmids (5/153 [3%]). Nearly all resistance genes were found in the context of known transposable elements. Very few structurally conserved plasmids with antibiotic resistance genes were identified, with the exception of an ∼90-kb F plasmid in sequence type 1193 (ST1193) isolates that appears to serve as a platform for resistance genes and may have virulence-related functions as well. Carriage of antibiotic resistance genes on transposable elements and mobile plasmids in commensal E. coli renders the resistome highly dynamic.IMPORTANCE Rising antibiotic resistance in human-associated bacterial pathogens is a serious threat to our ability to treat many infectious diseases. It is critical to understand how acquired resistance genes move in and through bacteria associated with humans, particularly for species such as Escherichia coli that are very common in the human gut but can also be dangerous pathogens. This work combined two distinct DNA sequencing approaches to allow us to explore the genomes of E. coli from college students to show that the antibiotic resistance genes these bacteria have acquired are usually carried on a specific type of plasmid that is naturally transferrable to other E. coli, and likely to other related bacteria.Entities:
Keywords: Escherichia colizzm321990; F plasmid; antibiotics
Mesh:
Substances:
Year: 2020 PMID: 32759337 PMCID: PMC7407071 DOI: 10.1128/mSphere.00709-20
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
Acquired resistance genes identified in commensal E. coli isolates
| Drug and resistance gene(s) | No. (%) identified in all isolates ( |
|---|---|
| β-Lactams | |
| | 31 (31) |
| | 5 (5) |
| | 1 (1) |
| | 2 (2) |
| Aminoglycosides | |
| | 27, 27 (27) |
| | 19 (19) |
| | 1 (1) |
| | 8 (8) |
| | 1 (1) |
| | 2 (2) |
| Sulfonamides | |
| | 18 (1) |
| | 29 (29) |
| Trimethoprim | |
| | 27 (27) |
| Tetracyclines | |
| | 18 (18) |
| | 6 (6) |
| | 4 (4) |
| Macrolides | |
| | 17 (17) |
| | 1 (1) |
| Phenicols | |
| | 2 (2) |
| | 2 (2) |
| Quinolones | |
| | 1 (1) |
blaTEM-1B in 29 isolates, blaTEM-1C in 1 isolate, and blaTEM-34 in 1 isolate.
blaCTX-M-14 in 3 isolates and blaCTX-M-27 in 2 isolates.
blaCMY-2 in 1 isolate and blaCMY-M-14 in 1 isolate.
aadA1 in 5 isolates, aadA2 in 3 isolates, and aadA5 in 11 isolates.
dfrA1 in 4 isolates, dfrA5 in 5 isolates, dfrA7 in 2 isolates, dfrA8 in 1 isolate, dfrA12 in 3 isolates, and dfrA17 in 12 isolates.
Plasmids and antibiotic resistance determinants in fully assembled commensal E. coli genomes
| Phylogroup | MLST | Isolate | Resistance | Genome | Size | Resistance genes (associated mobile elements) | Plasmid |
|---|---|---|---|---|---|---|---|
| A | 10 | SCU-103 | AMP, CEF, | pSCU-103-1 | 139 kb | F1A, F1B, | |
| SCU-118 | AMP, STR, | pSCU-118-1 | 85 kb | F1B' | |||
| B1 | 3695 | SCU-106 | STR, TET | pSCU-106-2 | 112 kb | F1B', FIC(II) | |
| SCU-308 | AMP, STR, | pSCU-308-1 | 152 kb | F1B', FII | |||
| B2 | 14 | SCU-387 | AMP, AZM | pSCU-387-2 | 39 kb | FII | |
| 73 | SCU-112 | AMP, CEF | pSCU-112-1 | 104 kb | F1B', FII, | ||
| 91 | SCU-121 | TET | pSCU-121-1 | 68 kb | FII | ||
| 95 | SCU-108 | AMP | pSCU-108-2 | 72 kb | FII | ||
| SCU-123 | AMP, STR, | pSCU-123-2 | 95 kb | B/O/K/Z (B/O) | |||
| SCU-306 | AZM, SXT | pSCU-306-1 | 129 kb | F1B, FII, | |||
| 131 | SCU-182 | AMP, GEN | pSCU-182-1 | 168 kb | F1A, F1B, | ||
| SCU-481 | AMP, AMC, | pSCU-481-1 | 144 kb | F1A, F1B, | |||
| 144 | SCU-125 | STR, SXT | pSCU-125-2 | 93 kb | B/O/K/Z (Z) | ||
| 357 | SCU-124 | AMP | pSCU-124-2 | 73 kb | FII | ||
| 1193 | SCU-147 | AMP, AZM, | pSCU-147-1 | 105 kb | F1A, F1B, | ||
| SCU-204 | STR, SUL | pSCU-204-1 | 88 kb | F1A, F1B, | |||
| SCU-390 | AMP, STR, | pSCU-390-1 | 91 kb | F1A, F1B', | |||
| 2279 | SCU-479 | AMP, AMC, | Chromosome | 5.2 Mb | |||
| D | 38 | SCU-164 | SXT, TET | Chromosome | 5.4 Mb | ||
| SCU-397 | AMP, CEF, | Chromosome | 5.3 Mb | ||||
| SCU-486 | AMP, CEF, | Chromosome | 5.2 Mb | ||||
| pSCU-486-1 | 84 kb | F1B', FII | |||||
| 69 | SCU-313 | AMP, AZM, | pSCU-313-1 | 105 kb | F1A, F1B' | ||
| SCU-482 | AMP, AZM, | pSCU-482-1 | 145 kb | F1B', FII, | |||
| 106 | SCU-318 | AMP, STR, | pSCU-318-1 | 105 kb | F1B, FII | ||
| 394 | SCU-105 | AMP, CEF, | Chromosome | 5.2 Mb | |||
| pSCU-105-1 | 173 kb | F1B, FII | |||||
| pSCU-105-2 | 9.7 kb | ||||||
| 963 | SCU-109 | AMP, AMC, | Chromosome | 5.0 Mb |
| ||
| pSCU-109-1 | 110 kb | F1B', FII, | |||||
| F | 62 | SCU-175 | AMP, AZM, | pSCU-175-1 | 124 kb | B/O/K/Z (Z) | |
| pSCU-175-2 | 72 kb | FII | |||||
| 379 | SCU-172 | AMP | pSCU-172-3 | 76 kb | FII | ||
| 648 | SCU-120 | AMP (int), | pSCU-120-1 | 143 kb | F1A, F1B', | ||
| pSCU-120-3 | 6.2 kb |
Abbreviations: AMP, ampicillin; AMC, amoxicillin-clavulanic acid; AZM, azithromycin; CEF, cephalothin; CHL, chloramphenicol; GEN, gentamicin; KAN, kanamycin; NAL, nalidixic acid; NOR, norfloxacin; STR, streptomycin; SUL, sulfamethoxazole alone; SXT, sulfamethoxazole-trimethoprim; TET, tetracycline; TMP, trimethoprim alone. “int” in parentheses indicates that the size of the zone of inhibition for the antibiotic met the manufacturer’s criteria for “intermediate” resistance. Note that quinolone resistance is reported here only when due to an acquired gene; resistance due to chromosomal mutations is reported in Table S1 in the supplemental material.
Identification of antibiotic resistance genes was done with ResFinder (48). A prime symbol indicates that the identified antibiotic resistance gene was incomplete (between 60 and 90% present). Mobile elements were identified using the Galileo Antimicrobial Resistance (GAMR) software (24). A prime symbol indicates that the transposable element was smaller than the published full version of the element. “flank” indicates that the resistance gene was not within the identified mobile element, but within 1 kb adjacent to it.
Identification of plasmid replicons was done with PlasmidFinder (21). A prime symbol indicates that the identified replicon sequence was incomplete (between 60 and 90% present).
Assembly was noncircular, suggesting gap of unknown size between ends.
FIG 1Conserved cluster of antibiotic resistance genes, transposable elements, and a class I integron in pSCU-313-1. Transposable elements and resistance genes were identified using ResFinder (48) and GAMR (24) and visualized using BioRender. IS elements are indicated by light gray boxes, with their name above the box; transposons and the class 1 integron are indicated by dark gray boxes, with their name above. Conserved inverted repeats known to be associated with transposable element boundaries are indicated by triangles above the boundaries. Dashed lines indicate breakpoints (defined by sequence alignment) of interrupted elements; partial elements are indicated by a prime symbol following their name. Antibiotic resistance genes are indicated by black arrows, with their name underneath.
FIG 2Acquired antibiotic resistance genes are primarily on large (>70-kb) plasmids in commensal E. coli. The y axis indicates the number of plasmids identified. Total (black and gray) bars indicate all plasmids in each size range from the genomes of antibiotic-resistant isolates (Table 2); black bars indicate only the plasmids that actually contained acquired antibiotic resistance genes.
FIG 3Rare small plasmids from commensal E. coli containing antibiotic resistance genes. Transposable elements and resistance genes were identified using ResFinder (48) and GAMR (24) and visualized using BioRender.
FIG 4A large conserved plasmid carrying antibiotic resistance is found in ST1193 isolates. (A) Alignment of plasmids pSCU-390-1, pSCU-204-1, pNMEC-075A (GenBank accession no. CP030112.1), and pC32_1 (GenBank accession no. CP041619.1) using BRIG (BLAST Ring Image Generator) (50); numbering starts at the F1B replicon. Select genetic regions shared by all of the plasmids are indicated on the outside ring, including plasmid replicons identified by Plasmid Finder. Antibiotic resistance genes in plasmid pSCU-390-1 are annotated in the inner ring. The variable region from approximately 40 to 60 kb, indicated by gaps in the alignment, is shown in panel B. (B) Comparison of the variable regions located between 40 and 60 kb in the conserved ST1193 plasmids. Transposable elements and resistance genes were identified using ResFinder (48) and GAMR (24) and visualized using BioRender. IS elements are indicated by light gray boxes, with their name above the box; transposons and the class 1 integron are indicated by dark gray boxes, with their name above. Conserved inverted repeats known to be associated with transposable element boundaries are indicated by triangles above the boundaries. Dashed lines indicate breakpoints (defined by sequence alignment) of interrupted elements; partial elements are indicated by a prime symbol following their name. Antibiotic resistance genes are indicated by black arrows, with their name underneath.